Navigation Links
Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease
Date:1/14/2009

LAFAYETTE, La., Jan. 14 /PRNewswire/ -- Lafayette General Medical Center (LGMC) announced today it is the first hospital in Louisiana to use a proprietary molecular genetic technology, which includes specific tests that more accurately diagnose respiratory infectious diseases. This technology, called Target Enriched Multiplex Polymerase Chain Reaction (Tem-PCR), allows physicians to test for multiple infections, both viral and bacterial, in as little as four hours. This faster and more precise testing helps physicians create efficient treatment protocols which generally improve clinical outcomes and decrease length of stay. Tem-PCR testing is provided by Diatherix Laboratories Inc., (www.diagnostixna.com), located in the Hudson-Alpha Institute for Biotechnology in Huntsville, Ala.

"This is highly advanced testing technology," said David Callecod, chief executive officer of LGMC. "Complex respiratory infections are a major challenge faced by hospitals. For the first time, using a revolutionary nasal wash test, our physicians will be able to quickly and more accurately diagnose a respiratory infection as well as co-infections, which may go undetected using more traditional testing. Our physicians will be able to simultaneously treat both primary and co-infections resulting in more positive clinical outcomes."

"Lafayette General is leading the way in providing patients with the benefits of genetic science," said Dennis Grimaud, chief executive officer of Diatherix Laboratories. "Hospitals throughout Louisiana and across the country are inundated with patients suffering from various types of respiratory diseases, all of which can be more cost-effectively and rapidly identified as well as more accurately coded using this new and exciting technology. The impact on the costs of treatment and the clinical outcomes is significant."

As the largest, full-service, acute-care medical center in the nine parishes of Acadiana, Lafayette General Medical Center's mission is to improve, maintain and restore the health of people in the communities we serve. LGMC is a community-owned hospital, and any profits are reinvested in the hospital for purchasing unsurpassed technology, maintaining a highly trained staff and adding new and improved services.

Diatherix Laboratories Inc. is located in the Hudson-Alpha Institute for Biotechnology in Huntsville, Ala. Diatherix operates as an independent clinical laboratory providing advanced multiplex molecular diagnostic services such as Tem-PCR to identify infectious disease to hospitals and the healthcare community. Diagnostic Network Alliance (DNA) (www.diagnostixna.com), with representative offices throughout the United States, is the exclusive US distributor for Diatherix Laboratory. DNA and Diatherix Laboratories share corporate administrative headquarters in Brentwood, Tenn.


'/>"/>
SOURCE Diatherix Laboratories Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Sinovac Announces Postponement of Annual General Meeting
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. 3SBio Inc. to Hold Annual General Meeting
7. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
8. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
9. Elbit Medical Imaging Ltd. Announces Results of Its Annual General Meeting
10. Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7, 2007
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced the three Winners and six Finalists of the 2017 Blavatnik Regional Awards ... the Blavatnik Family Foundation and administered by the New York Academy of Sciences ...
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... ... 2017 , ... At its national board meeting in North ... the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology and ... ARCS Alumni Hall of Fame . ASTER Labs is a technology development ...
Breaking Biology Technology:
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):